Spread the love

Stem Cell Care India is only using adult stem cells (also called somatic stem cells) in its treatment protocols and does not offer embryonic stem cells. It is imperative to remember that while embryonic stem cells might have more regenerative potential; those might also bring serious medical complications. At SCCI, our treatment protocols do not compromise on safety and our adult stem cells have been used effectually for more than 22,500 patients with no serious adverse reaction reported. The adult stem cells provided in our treatment protocols come from two diverse sources: umbilical cord tissue and umbilical cord blood. This permits us to provide our patients with Umbilical Cord Blood Stem Cells (UCBSC) and Umbilical Cord Mesenchymal Stem Cells (UCMSC) individually or in combination contingent on every patient’s specific condition and requisite. Umbilical cord derived stem cells do not draw any concern from the scientific community and have been recognized effective for a catholic array of conditions.

Umbilical Cord Blood-Derived Stem Cells (UCBSC)

For a catholic array of neurological conditions such as neurodegenerative diseases, brain injuries, visual impairments, motor neuron diseases, muscular dystrophies and hearing loss, Stem Cell Care suggests treatment using umbilical cord blood stem cells (UCBSC). Our umbilical cord blood stem cells comprise of numerous subsets of stem cells including Hematopoietic Stem Cells (HSC), Endothelial Progenitor Cells (EPC), Mesenchymal Stem Cells (MSC) and more, that permit differentiation into all blood cell lineages including immune cells from the innate and adaptive immune system as well as neural/nerve cells, muscle fibers, retinal ganglion cells, hepatic cells, chondrocytes (cartilage) and osteocytes (bone). Furthermore, this combination of stem cells is able to modulate the immune system (lessenswelling or upsurge immune response contingent on needs), release cytokines and growth factors, such as glia derived neurotrophic factor (GDNF), brain derived neurotrophic factor (BDNF), nerve growth factors (NGF), neurotrophin 3 (NT-3), neurotrophin 4/5 (NT 4/5), and stimulate patient’s own stem cells as well which further encourages regeneration. At this phase of stem cell research, it is believed that maximum of the advantages patients report have come from the cell growth factors and cytokines that are released by the stem cells after their administration.

Umbilical Cord-Derived Mesenchymal Stem Cells (UCMSC)

Centered upon research publications and experience, SCCI protocols also use umbilical cord mesenchymal stem cells (UCMSC) for suitable conditions autoimmune and inflammatory diseases. These boosters encompass a higher percentage of mesenchymal stem cells than the umbilical cord blood stem cell injections and closely looks like the makeup of stem cells present in patient’s’ own bone marrow. These cells not only secrete imperative cytokines and growth factors, such as brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factors (GDNF), transforming growth factor beta 1 (TGFβ1), Ciliary neurotrophic factor (CNTF), neurotrophin 3 (NT-3), which might play a role in neuroprotection; but also are able to  segregate into desired cell types. Last but not the least, UCMSC can regulate the immune system decreasing inflammation, scarring and cell death to keep organs and human body young and healthy and to improve the condition of degenerative sicknesses.